TG Therapeutics IncNASDAQ:TGTX
- LAST PRICE19.7000
- TODAY'S CHANGE (%)0.6900 (3.6297%)
- Bid / Lots19.6900/ 4
- Ask / Lots19.7000/ 3
- Open / Previous Close19.2100 / 19.0100
- Day Range
- 52 Week Range
- Volume1,767,140
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TGTX |
|---|---|---|
| 09:32 ET | 53482 | 19.095 |
| 09:34 ET | 8960 | 19.19 |
| 09:36 ET | 28519 | 19.18 |
| 09:38 ET | 18655 | 19.23 |
| 09:39 ET | 5922 | 19.23 |
| 09:41 ET | 10005 | 19.08 |
| 09:43 ET | 10729 | 19.0795 |
| 09:45 ET | 20432 | 18.95 |
| 09:48 ET | 28187 | 18.92 |
| 09:50 ET | 17079 | 18.91 |
| 09:52 ET | 12728 | 18.85 |
| 09:54 ET | 10327 | 18.86 |
| 09:56 ET | 11638 | 18.93 |
| 09:57 ET | 11001 | 18.92 |
| 09:59 ET | 6975 | 18.97 |
| 10:01 ET | 36146 | 18.9 |
| 10:03 ET | 6678 | 18.93 |
| 10:06 ET | 3603 | 18.98 |
| 10:08 ET | 10691 | 18.93 |
| 10:10 ET | 12690 | 18.9 |
| 10:12 ET | 1422 | 18.93 |
| 10:14 ET | 6515 | 18.98 |
| 10:15 ET | 4883 | 18.98 |
| 10:17 ET | 3498 | 18.9631 |
| 10:19 ET | 4052 | 18.88 |
| 10:21 ET | 10882 | 18.88 |
| 10:24 ET | 5023 | 18.95 |
| 10:26 ET | 8566 | 18.96 |
| 10:28 ET | 3934 | 18.87 |
| 10:30 ET | 3794 | 18.9 |
| 10:32 ET | 9681 | 18.9146 |
| 10:33 ET | 5876 | 18.95 |
| 10:35 ET | 22994 | 19.022 |
| 10:37 ET | 11169 | 19.04 |
| 10:39 ET | 51587 | 19.33 |
| 10:42 ET | 20604 | 19.26 |
| 10:44 ET | 5637 | 19.22 |
| 10:46 ET | 7979 | 19.27 |
| 10:48 ET | 2170 | 19.26 |
| 10:50 ET | 6801 | 19.18 |
| 10:51 ET | 3287 | 19.19 |
| 10:53 ET | 6230 | 19.185 |
| 10:55 ET | 2570 | 19.25 |
| 10:57 ET | 64717 | 19.35 |
| 11:00 ET | 5607 | 19.31 |
| 11:02 ET | 3791 | 19.3 |
| 11:04 ET | 9228 | 19.25 |
| 11:06 ET | 12946 | 19.275 |
| 11:08 ET | 12605 | 19.3499 |
| 11:09 ET | 9399 | 19.29 |
| 11:11 ET | 4441 | 19.35 |
| 11:13 ET | 4141 | 19.37 |
| 11:15 ET | 5484 | 19.34 |
| 11:18 ET | 3303 | 19.36 |
| 11:20 ET | 19119 | 19.3422 |
| 11:22 ET | 1710 | 19.32 |
| 11:24 ET | 10430 | 19.365 |
| 11:26 ET | 27178 | 19.41 |
| 11:27 ET | 10282 | 19.43 |
| 11:29 ET | 15317 | 19.46 |
| 11:31 ET | 8826 | 19.43 |
| 11:33 ET | 36151 | 19.515 |
| 11:36 ET | 54620 | 19.4242 |
| 11:38 ET | 3286 | 19.39 |
| 11:40 ET | 11363 | 19.38 |
| 11:42 ET | 6518 | 19.385 |
| 11:44 ET | 5642 | 19.44 |
| 11:45 ET | 2968 | 19.41 |
| 11:47 ET | 4427 | 19.37 |
| 11:49 ET | 6624 | 19.4501 |
| 11:51 ET | 5400 | 19.4458 |
| 11:54 ET | 4454 | 19.4399 |
| 11:56 ET | 15108 | 19.435 |
| 11:58 ET | 6153 | 19.45 |
| 12:00 ET | 7655 | 19.44 |
| 12:02 ET | 85172 | 19.3001 |
| 12:03 ET | 7353 | 19.355 |
| 12:05 ET | 3047 | 19.39 |
| 12:07 ET | 4820 | 19.43 |
| 12:09 ET | 11840 | 19.4574 |
| 12:12 ET | 4640 | 19.43 |
| 12:14 ET | 11061 | 19.45 |
| 12:16 ET | 781 | 19.46 |
| 12:18 ET | 3105 | 19.486 |
| 12:20 ET | 66678 | 19.47 |
| 12:21 ET | 10226 | 19.535 |
| 12:23 ET | 16212 | 19.52 |
| 12:25 ET | 8096 | 19.54 |
| 12:27 ET | 10097 | 19.655 |
| 12:30 ET | 6713 | 19.66 |
| 12:32 ET | 4100 | 19.67 |
| 12:34 ET | 16513 | 19.72 |
| 12:36 ET | 2642 | 19.73 |
| 12:38 ET | 10794 | 19.67 |
| 12:39 ET | 3784 | 19.68 |
| 12:41 ET | 9496 | 19.7 |
| 12:43 ET | 20079 | 19.785 |
| 12:45 ET | 53631 | 19.9069 |
| 12:48 ET | 18346 | 19.91 |
| 12:50 ET | 26454 | 19.85 |
| 12:52 ET | 4518 | 19.8 |
| 12:54 ET | 20184 | 19.8062 |
| 12:56 ET | 4596 | 19.77 |
| 12:57 ET | 9595 | 19.77 |
| 12:59 ET | 7772 | 19.68 |
| 01:01 ET | 6450 | 19.66 |
| 01:03 ET | 21068 | 19.7 |
| 01:06 ET | 4762 | 19.7 |
| 01:08 ET | 5348 | 19.7 |
| 01:10 ET | 5370 | 19.66 |
| 01:12 ET | 8882 | 19.63 |
| 01:14 ET | 4336 | 19.66 |
| 01:15 ET | 6800 | 19.7 |
Jun 11, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
TG Therapeutics Inc | 2.9B | 89.3x | --- |
Twist Bioscience Corp | 2.8B | -14.7x | --- |
Arrowhead Pharmaceuticals Inc | 3.2B | -6.1x | --- |
MorphoSys AG | 2.8B | -5.5x | --- |
ADMA Biologics Inc | 2.7B | -579.7x | --- |
Denali Therapeutics Inc | 3.0B | -22.2x | --- |
Company Information
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Contact Information
- Headquarters
- 3020 Carrington Mill Blvd., Suite 475MORRISVILLE, NC, United States 27560-5435
- Phone
- 212-554-4484
- Fax
- 212-554-4531
Executives
- Chairman of the Board, President, Chief Executive Officer
- Michael Weiss
- Chief Financial Officer, Treasurer, Corporate Secretary
- Sean Power
- Lead Independent Director
- Laurence Charney
- Independent Director
- Yann Echelard
- Independent Director
- Kenneth Hoberman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 89.3x |
Price/Sales (TTM) | 10.2 |
Price/Cash Flow (TTM) | 71.0x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
